Gene · 1595
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coumarin-Based Antifungal Leads: Design, Synthesis, Mechanistic Insights, and Synergistic Activity. | Chem Biodivers | 2026 | 42814860 | PubTator, text mining | PubMed |
| Synthesis, molecular docking and biological activity assessment of novel 1,3,4-oxadiazole derivatives as broad-spectrum antifungal candidates. | RSC Adv | 2026 | 42813028 | PubTator, text mining | PubMed |
| CAFs-mediated histone lactylation reprograms cholesterol metabolism in colorectal cancer to drive CD8+ T cell immunosuppression. | J Pathol | 2026 | 42711289 | PubTator, text mining | PubMed |
| Linker Engineering of Hybrid Triazole-Thiazolidine Antifungals Identifies a Promising Lead Against Drug-Resistant Candida Species. | Pharmaceuticals (Basel) | 2026 | 42653757 | PubTator, text mining | PubMed |
| Virulence Profiles and Fungicide-Target-Gene Variability in Puccinia graminis f. sp. tritici Populations from Russian Regions. | J Fungi (Basel) | 2026 | 42646131 | PubTator, text mining | PubMed |
| Dual-Targeting, Hybrid Antifungal Agents Targeting Candida albicans-An Overview. | Chem Biol Drug Des | 2026 | 42630000 | PubTator, text mining | PubMed |
| Design, synthesis, molecular modelling and biological evaluation of oxiconazole-based 1,2,3-triazoles as dually acting antifungal and antitumor agents. | Sci Rep | 2026 | 42601411 | PubTator, text mining | PubMed |
| Design and mechanistic evaluation of chalcone-quinoline-triazole hybrids as antifungal CYP51 inhibitors. | Med Chem Res | 2026 | 42599305 | PubTator, text mining | PubMed |
| In Vitro Antifungal Evaluation, GC-MS Profiling, and Molecular Docking of Eruca sativa Oil, Clove Oil, and Fusarium chlamydosporum Extract Against the Dermatophyte Trichophyton interdigitale. | Curr Microbiol | 2026 | 42461428 | PubTator, text mining | PubMed |
| Spatiotemporal Distribution, Mechanisms, and Field Efficacy of Tebuconazole Resistance in Blumeria graminis f. sp. tritici (Bgt) Populations in Hebei, Henan, and Shandong Provinces, China. | Plant Dis | 2026 | 42449206 | PubTator, text mining | PubMed |
| Design, Synthesis of Pyridine Based Thiazolidine Derivatives and Investigation of Antimicrobial Activity Targeting Ergosterol Biosynthesis via In Vitro and In Silico Approaches. | Chem Biol Drug Des | 2026 | 42429071 | PubTator, text mining | PubMed |
| The Expanding Role of Indole Scaffolds in Combating Antimicrobial Resistance. | Drug Dev Res | 2026 | 42421449 | PubTator, text mining | PubMed |
| Triazoles as enzyme inhibitors: synthetic advances, mechanism of action, molecular docking studies and structure-activity relationships. | Mol Divers | 2026 | 42400758 | PubTator, text mining | PubMed |
| Multifaceted anti-infective efficacy of Alstonia scholaris (Mizoram chemotype) against fungal, malarial, and intestinal helminth pathogens: in vitro validation and molecular docking insights. | Vet World | 2026 | 42344326 | PubTator, text mining | PubMed |
| Follicular Fluid Meiosis-Activating Sterol (FF-MAS) Enhances Lens Transparency By Increasing αA-Crystallin Solubility In Cataracts. | J Vis Exp | 2026 | 42296026 | PubTator, text mining | PubMed |
| From anti-fungal to potential neurotherapeutic: Posaconazole as an effective inhibitor of cellular TDP-43 pathology. | bioRxiv | 2026 | 42282588 | PubTator, text mining | PubMed |
| Fungicidal Activity and In Silico Studies of Triazoles Derived From Glycerol Against Neocosmospora falciformis, A Causal Agent of Guava Tree Decline. | Chem Biodivers | 2026 | 42246282 | PubTator, text mining | PubMed |
| Identification of ZINC database-derived antitrypanosomal candidates targeting Trypanosoma congolense lysosomal-α-mannosidase using computational, biochemical and in vivo methods. | Exp Parasitol | 2026 | 42235743 | PubTator, text mining | PubMed |
| Soil Reservoirs of Antifungal-Resistant Fungi: Implications for Plant Disease Management with a Focus on Fusarium. | Microorganisms | 2026 | 42197405 | PubTator, text mining | PubMed |
| Deeply Optimized Nanopesticides Based on Novel Pyrimidine-Amide-Imidazole Derivatives as Dual-Target (SDH/CYP51) Fungicides for Plant Pathogenic Fungal Resistance. | J Agric Food Chem | 2026 | 42132341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1595/papers